Stay updated on Savolitinib for MET Amplified Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Savolitinib for MET Amplified Colorectal Cancer Clinical Trial page.

Latest updates to the Savolitinib for MET Amplified Colorectal Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedVersion updated from v3.4.3 to v3.5.0; no visible changes to the Study Details content were observed.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 to reflect an updated document version on the page.SummaryDifference0.0%

- Check47 days agoChange Detected- Revision updated from v3.4.1 to v3.4.2. This appears to be a minor platform/version update that does not affect the study information or functionality presented on the page.SummaryDifference0.0%

- Check54 days agoChange DetectedFooter revision tag updated from v3.4.0 to v3.4.1.SummaryDifference0.0%

- Check61 days agoChange DetectedGlossary is now shown on the page, and the metadata includes 'Last Update Submitted that Met QC Criteria'. The footer also displays 'Revision: v3.4.0' and the older phrasing 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data' have been removed.SummaryDifference0.2%

- Check75 days agoChange DetectedRevision: v3.3.4 was added to the page, replacing the previous v3.3.3 revision. No clinical trial content, eligibility criteria, or location details were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Savolitinib for MET Amplified Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Savolitinib for MET Amplified Colorectal Cancer Clinical Trial page.